Table 1 Calculated patient doses delivered to regions of interest for kVCT, MVCT and hybrid plans
From: Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses
| Â | Â | Patient 1 | Patient 2 | Patient 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Organ | kVCT | MVCT | Hybrid | kVCT | MVCT | Hybrid | kVCT | MVCT | Hybrid |
D5MVCT | B | 67.1 | 63.7 | 67.6 | 81.8 | 77.2 | 80.9 | 78.6 | 80.3 | 78.7 |
R | 76.0 | 75.6 | 75.3 | 65.0 | 70.5 | 70.9 | 77.6 | 81.2 | 77.7 | |
D10MVCT | B | 62.5 | 60.8 | 62.3 | 75.1 | 75.6 | 75.3 | 77.0 | 77.1 | 77.1 |
R | 69.0 | 70.3 | 68.5 | 59.1 | 64.1 | 64.4 | 77.4 | 80.6 | 77.5 | |
D25MVCT | B | 48.1 | 48.4 | 48.4 | 50.7 | 57.1 | 55.6 | 67.8 | 67.8 | 68.1 |
R | 51.4 | 51.7 | 51.7 | 45.2 | 48.4 | 50.0 | 74.8 | 72.0 | 74.9 | |
D35MVCT | B | 41.2 | 39.9 | 42.3 | 39.4 | 49.0 | 46.0 | 58.8 | 59.5 | 59.0 |
R | 43.5 | 42.7 | 44.0 | 37.5 | 41.5 | 40.1 | 69.5 | 63.5 | 69.4 | |
D50MVCT | B | 30.9 | 33.0 | 31.9 | 25.4 | 37.3 | 34.2 | 48.1 | 47.2 | 48.1 |
R | 35.7 | 33.0 | 36.1 | 31.9 | 35.1 | 34.2 | 59.2 | 45.2 | 59.5 | |
D99 | P | 72.2 | 72.8 | 72.2 | 74.2 | 73.7 | 74.6 | 71.9 | 73.8 | 71.8 |
D1 | P | 83.6 | 81.4 | 83.5 | 89.1 | 82.6 | 85.0 | 79.6 | 85.1 | 79.7 |